-

Trinity Life Sciences Launches Agency Optimization Benchmark

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, has launched the TGaS Advisors’ Agency Optimization Benchmark. The new benchmark helps life sciences companies understand how their utilization of agencies compares to industry peers.

Drawing upon proprietary data collected from the TGaS Member Network, the Agency Optimization Benchmark provides a detailed comparative assessment for brand teams and commercial operations leaders in areas such as:

  • Agency investment
  • Number of agencies utilized
  • Agency headcount allocated to brands
  • Brand lifecycle influence on agency utilization
  • Breakdown of agency utilization by capabilities
  • Rate card averages and year-over-year rate increases

“In the past, life sciences companies have been forced to rely solely on internal data, or no data at all, when making critical agency investment and resourcing decisions,” said Jerry Luciano, Vice President of Omnichannel Marketing at TGaS Advisors, a division of Trinity Life Sciences. “Brand teams and commercial operations leaders can use the Agency Optimization Benchmark to get peer-based perspectives that will allow them to drive greater efficiency with new or longstanding agency partners.”

“Companies need to ensure their agency resources are focused on the right things,” said Chris Weleski, Vice President of Marketing Operations and Medical/Regulatory/Legal at TGaS Advisors, a division of Trinity Life Sciences. “Agency budgets may be disproportionately allocated to account and project management instead of creative and strategy. The Agency Optimization Benchmark gives companies the data and insights they need to reallocate resources and spend appropriately to optimize investment for their organizations.”

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With over 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom